Cantitate/Preț
Produs

Diabetes - Perspectives in Drug Therapy: Handbook of Experimental Pharmacology, cartea 203

Editat de Mathias Schwanstecher
en Limba Engleză Paperback – 21 apr 2013
The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 278532 lei  43-57 zile
  Springer Berlin, Heidelberg – 21 apr 2013 278532 lei  43-57 zile
Hardback (1) 279050 lei  43-57 zile
  Springer Berlin, Heidelberg – 14 mar 2011 279050 lei  43-57 zile

Din seria Handbook of Experimental Pharmacology

Preț: 278532 lei

Preț vechi: 293193 lei
-5% Nou

Puncte Express: 4178

Preț estimativ în valută:
53311 55563$ 44379£

Carte tipărită la comandă

Livrare economică 06-20 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642267420
ISBN-10: 3642267424
Pagini: 424
Ilustrații: XIII, 408 p. 69 illus.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.59 kg
Ediția:2011
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Preface. Targeting type 2 diabetes. Dual acting and pan-PPAR activators as potential anti-diabetic therapies. GLP-agonists and Dipeptidyl-Peptidase IV Inhibitors. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes. Inhibitors of 11b-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy. Nampt and its potential role in inflammation and type 2 diabetes. Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance. Overcoming Insulin Resistance with Ciliary Neurotrophic Factor. Thermogenesis and related metabolic targets in anti-diabetic therapy. Interleukin targeted therapy for metabolic syndrome and type 2 diabetes. Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes. AMP-activated protein kinase and metabolic control. Mitochondria as potential targets in antidiabetic therapy. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects

Textul de pe ultima copertă

Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll.The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.

Caracteristici

Features excellent reviews of international experts on cutting edge diabetes research Provides a detailed up to date overview of cellular and molecular mechanisms involved in obesity driven development of type 2 diabetes Focuses on potential novel drug targets, thus opening the way for innovative strategies in diabetes and obesity therapy Includes supplementary material: sn.pub/extras